Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Lack of immunity against rubella among Italian young adults

Authors: Gallone Maria Serena, Gallone Maria Filomena, Larocca Angela Maria Vittoria, Germinario Cinzia, Tafuri Silvio

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

To support the evaluation of the 2010-15 National Plan for Measles and Congenital Rubella Elimination, the authors designed and performed a serosurveillance survey to verify the immunity/susceptibility rate against rubella among Apulian young adults.

Methods

The study was carried out from May 2011 to June 2012 in the Department of Transfusion Medicine/Blood Bank of Policlinico General Hospital in Bari. Subjects were enrolled by a convenience sampling. For each enrolled patient a 5 ml serum sample was collected and tested for anti-rubella IgG. The geometrical means (GMT) of anti-rubella IgG was calculated. T student test or ANOVA test, when appropriate, was used to compare the means of age per gender and GMT of anti-rubella IgG titres per age classes. Chi-square test was used to compare the proportion of anti-rubella IgG positive subjects per gender and per age classes. For all tests, a p value <0.05 was considered as significant.

Results

At the end of the study 1764 subjects were enrolled, 1362 (77.2%) of which were male. The mean age was 38.4 ± 11.7 years (range: 17-65). 86.7% (95% CI = 85.0-88.2) had a positive titre of anti-rubella IgG. GMT of anti-rubella IgG titre was 4.3.
The proportion of positive subjects was of 76.8% (n = 279/363; 95% CI = 72.2-81.1) in persons aged 18-26 years; 88.1% (n = 310/352; 95% CI = 84.2-91.3) in 27-35 year-old people; 88.5% (n = 464/524; 95% CI = 85.5-91.1) in 36-45 year-old people; 90.7% (n = 350/386; 95% CI = 87.3-93.4) among people aged 46-55 years and 90.6% (n = 126/139; 95% CI = 84.5-94.9) in 55-65 year-old people (Chi-square = 39.7; p < 0.0001). GMT of anti-rubella IgG titre was 4.3 (4.3 in male and 4.2 in female, t = 2.2; p = 0.03) and seems to differ dividing the enrolled subjects by age group (F = 14.3; p < 0.0001).

Conclusions

According to our data, too many women of child-bearing age are still unprotected from rubella in the elimination era and in this scenario the public health efforts should be oriented to catch-up activities.
Literature
1.
go back to reference Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S. Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009. J Infect Dis. 2011;204 Suppl 1:S24–7.CrossRefPubMed Reef SE, Strebel P, Dabbagh A, Gacic-Dobo M, Cochi S. Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009. J Infect Dis. 2011;204 Suppl 1:S24–7.CrossRefPubMed
2.
go back to reference Plotkin SA. Rubella vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. Philadelphia: W.B Saunders; 1999. p. 409–44. Plotkin SA. Rubella vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. Philadelphia: W.B Saunders; 1999. p. 409–44.
3.
go back to reference Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, Emiroglu N. Measles and rubella in the World Health Organization European region: diversity creates challenges. J Infect Dis. 2003;187 Suppl 1:S191–7.CrossRefPubMed Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, Emiroglu N. Measles and rubella in the World Health Organization European region: diversity creates challenges. J Infect Dis. 2003;187 Suppl 1:S191–7.CrossRefPubMed
4.
go back to reference Irons B, Lewis MJ, Dahl-Regis M, Castillo-Solórzano C, Carrasco PA, de Quadros CA. Strategies to eradicate rubella in the English-speaking Caribbean. Am J Public Health. 2000;90(10):1545–9.CrossRefPubMedPubMedCentral Irons B, Lewis MJ, Dahl-Regis M, Castillo-Solórzano C, Carrasco PA, de Quadros CA. Strategies to eradicate rubella in the English-speaking Caribbean. Am J Public Health. 2000;90(10):1545–9.CrossRefPubMedPubMedCentral
6.
go back to reference Centers for Disease Control and Prevention (CDC). Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004. MMWR Morb Mortal Wkly Rep. 2005;54(7):175–8. Centers for Disease Control and Prevention (CDC). Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004. MMWR Morb Mortal Wkly Rep. 2005;54(7):175–8.
7.
go back to reference Jankovic D. Rubella and CRS overview for WHO Europe. Progress Toward Rubella Elimination and CRS Prevention in Europe. Rome: The MMWR is published by The Centers for Disease Control and Prevention; 2012. Jankovic D. Rubella and CRS overview for WHO Europe. Progress Toward Rubella Elimination and CRS Prevention in Europe. Rome: The MMWR is published by The Centers for Disease Control and Prevention; 2012.
8.
go back to reference Manfredi P, Williams JR, Ciofi Degli Atti ML, Salmaso S. Measles elimination in Italy: projected impact of the National Elimination Plan. Epidemiol Infect. 2005;133(1):87–97.CrossRefPubMedPubMedCentral Manfredi P, Williams JR, Ciofi Degli Atti ML, Salmaso S. Measles elimination in Italy: projected impact of the National Elimination Plan. Epidemiol Infect. 2005;133(1):87–97.CrossRefPubMedPubMedCentral
11.
go back to reference ICONA Working Group. ICONA 2008: Indagine di copertura vaccinale nazionale nei bambini e negli adolescenti. [ICONA 2008: national vaccination coverage survey among children and adolescents]. Rapporti ISTISAN. 09/29. Rome: Istituto Superiore di Sanità; 2009. Available from: http://www.iss.it/binary/publ/cont/09_29_web.pdf. Accessed 4 Nov 2014. Italian. ICONA Working Group. ICONA 2008: Indagine di copertura vaccinale nazionale nei bambini e negli adolescenti. [ICONA 2008: national vaccination coverage survey among children and adolescents]. Rapporti ISTISAN. 09/29. Rome: Istituto Superiore di Sanità; 2009. Available from: http://​www.​iss.​it/​binary/​publ/​cont/​09_​29_​web.​pdf. Accessed 4 Nov 2014. Italian.
12.
go back to reference Giambi C, Filia A, Rota MC, Del Manso M, Declich S, Nacca G, Rizzuto E, Bella A, Regional contact points for rubella. Congenital rubella still a public health problem in Italy: analysis of national surveillance data from 2005 to 2013. Euro Surveill. 2015;20(16):21103. Giambi C, Filia A, Rota MC, Del Manso M, Declich S, Nacca G, Rizzuto E, Bella A, Regional contact points for rubella. Congenital rubella still a public health problem in Italy: analysis of national surveillance data from 2005 to 2013. Euro Surveill. 2015;20(16):21103.
13.
go back to reference Tafuri S, Gallone MS, Gallone MF, Pappagallo MT, Larocca A, Germinario C. Monitoring the process of measles elimination by serosurveillance data: The Apulian 2012 study. Vaccine. 2016;34(18):2092–5.CrossRefPubMed Tafuri S, Gallone MS, Gallone MF, Pappagallo MT, Larocca A, Germinario C. Monitoring the process of measles elimination by serosurveillance data: The Apulian 2012 study. Vaccine. 2016;34(18):2092–5.CrossRefPubMed
14.
go back to reference Cozza V, Martinelli D, Cappelli MG, Tafuri S, Fortunato F, Prato R. Further efforts in the achievement of congenital rubella syndrome/rubella elimination: alternative sources of information for retrospective case-finding, Puglia region, Italy, 2003-2011. Hum Vaccin Immunother. 2015;11(1):220–4. Cozza V, Martinelli D, Cappelli MG, Tafuri S, Fortunato F, Prato R. Further efforts in the achievement of congenital rubella syndrome/rubella elimination: alternative sources of information for retrospective case-finding, Puglia region, Italy, 2003-2011. Hum Vaccin Immunother. 2015;11(1):220–4.
15.
go back to reference Nardone A, Miller E. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Euro Surveill. 2004;9(4)5–7. Nardone A, Miller E. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Euro Surveill. 2004;9(4)5–7.
16.
go back to reference ISTAT. Demography in numbers. Available at demo.istat.it, Accessed 20 Mar 2016. ISTAT. Demography in numbers. Available at demo.istat.it, Accessed 20 Mar 2016.
17.
go back to reference Dimech W, Panagiotopoulos L, Francis B, Laven N, Marler J, Dickeson D, Panayotou T, Wilson K, Wootten R, Dax EM. Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter. J Clin Microbiol. 2008;46(6):1955–60.CrossRefPubMedPubMedCentral Dimech W, Panagiotopoulos L, Francis B, Laven N, Marler J, Dickeson D, Panayotou T, Wilson K, Wootten R, Dax EM. Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter. J Clin Microbiol. 2008;46(6):1955–60.CrossRefPubMedPubMedCentral
18.
go back to reference Gilbert GL, Escott RG, Gidding HF, Turnbull FM, Heath TC, Mcintyre PB, Burgess MA. Impact of the Australian Measles Control Campaign on immunity to measles and rubella. Epidemiol Infect. 2001;127:297–303.PubMedPubMedCentral Gilbert GL, Escott RG, Gidding HF, Turnbull FM, Heath TC, Mcintyre PB, Burgess MA. Impact of the Australian Measles Control Campaign on immunity to measles and rubella. Epidemiol Infect. 2001;127:297–303.PubMedPubMedCentral
19.
go back to reference Smits G, Mollema L, Hahné S, de Melker H, Tcherniaeva I, van der Klisa F, Berbersa G. Seroprevalence of rubella antibodies in The Netherlands after 32 yearsof high vaccination coverage. Vaccine. 2014;32:1890–5.CrossRefPubMed Smits G, Mollema L, Hahné S, de Melker H, Tcherniaeva I, van der Klisa F, Berbersa G. Seroprevalence of rubella antibodies in The Netherlands after 32 yearsof high vaccination coverage. Vaccine. 2014;32:1890–5.CrossRefPubMed
20.
go back to reference Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988–1994. Clin Infect Dis. 2001;33:1279–86.CrossRefPubMed Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988–1994. Clin Infect Dis. 2001;33:1279–86.CrossRefPubMed
21.
go back to reference Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile. Eur J Public Health. 2012;22(1):133–9.CrossRefPubMed Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile. Eur J Public Health. 2012;22(1):133–9.CrossRefPubMed
22.
go back to reference Cooper LZ. Current lessons from 20th Century Serosurveillance data on rubella. Clin Infect Dis. 2001;33:1287.CrossRefPubMed Cooper LZ. Current lessons from 20th Century Serosurveillance data on rubella. Clin Infect Dis. 2001;33:1287.CrossRefPubMed
Metadata
Title
Lack of immunity against rubella among Italian young adults
Authors
Gallone Maria Serena
Gallone Maria Filomena
Larocca Angela Maria Vittoria
Germinario Cinzia
Tafuri Silvio
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2295-y

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue